UniTo-San Luigi Gonzaga Study on Microbiota and Multiple Sclerosis
Date of the event:
The study on microbiota and multiple sclerosis is an Italian multicentre research project coordinated by the University of Turin and the San Luigi Gonzaga University Hospital, the results of which were made public on 17 November 2026. The work identified, already at the time of multiple sclerosis diagnosis, gut microbiota features associated with a different course of the disease over the following year [1][2].
The study
The research was published in the October 2026 issue of eBioMedicine, a journal of The Lancet group [1][2]. The interdisciplinary team that carried it out is made up of neurologists, biologists and computational analysis experts, led by Marinella Clerico, professor of Neurology at the Department of Clinical and Biological Sciences of the University of Turin and director of the Specialist Neurological Pathologies Unit at the San Luigi Gonzaga University Hospital, Simona Rolla, a researcher in the same department, and Francesca Cordero, of the Department of Computer Science of the Turin university. The research was also carried out by Alessandro Maglione and Rachele Rosso, of the Department of Clinical and Biological Sciences, and Dora Tortarolo, of the Department of Computer Science, together with a multicentre study group [1][2].
Method and results
The researchers analysed faecal samples from 53 people at the time of their multiple sclerosis diagnosis, comparing them with samples from 55 healthy donors. Using high-resolution metagenomic techniques, which analyse the genetic material of the microorganisms present in the samples, the composition of the gut microbial communities was reconstructed and related to the clinical data collected during the first year after diagnosis and to information on lesions detected by magnetic resonance imaging, considering their number, location and disease activity [1][2].
In addition to the differences found in microbiota composition between people with multiple sclerosis and healthy donors, the analysis identified two subgroups of patients with distinct clinical features and a different risk of progression over the twelve months following diagnosis. In the subgroup associated with a less favourable prognosis, motor symptoms and spinal cord lesions were more frequent, already in the early stages [2].
Outlook
The study is based on the hypothesis of the role of the gut-brain axis, the network of immune, metabolic and nerve signals between gut microorganisms and the central nervous system, which can influence the inflammatory and neurodegenerative processes involved in multiple sclerosis. The findings pave the way for the development of early, non-invasive prognostic tools based on microbiota analysis, useful for assessing the disease's progression from its earliest stages [1][2].
Related articles: University of Turin study on the microbiota and multiple sclerosis (November 2026)
Sources
- sclerosi multipla studio intestino torino — La Stampa, 17 November 2026
- Sclerosi multipla, a Torino uno studio sul microbiota intestinale: così potrebbe anticipare il decorso della malattia — CronacaQui Torino, 17 November 2026